Alterity Therapeutics Limited - stock earnings
ATHE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -1.9 million USD | 553196 USD |
| 2022Q3 | -1.7 million USD | 495094 USD |
| 2022Q2 | -1.5 million USD | 658447 USD |
| 2022Q1 | -1.8 million USD | 774373 USD |
| 2021Q4 | -1.7 million USD | 622585 USD |
| 2021Q3 | -1.7 million USD | 616239 USD |
| 2021Q2 | -1.9 million USD | 690524 USD |
| 2021Q1 | -1.9 million USD | 708447 USD |
| 2020Q4 | -2.5 million USD | 559108 USD |
| 2020Q3 | -2.2 million USD | 483370 USD |
| 2020Q2 | -1.9 million USD | -441813 USD |
| 2020Q1 | -1.5 million USD | -351916 USD |
| 2019Q4 | -1.4 million USD | 455673 USD |
| 2019Q3 | -1.3 million USD | 424847 USD |
| 2019Q2 | -1.7 million USD | 620775 USD |
| 2019Q1 | -1.8 million USD | 634791 USD |
| 2018Q4 | -1.3 million USD | 602074 USD |
| 2018Q3 | -1.4 million USD | 631728 USD |
| 2018Q2 | -1.3 million USD | 448185 USD |
| 2018Q1 | -1.4 million USD | 486586 USD |
| 2017Q4 | -1.1 million USD | 449392 USD |
| 2017Q3 | -1.1 million USD | 454558 USD |
| 2017Q2 | -1.1 million USD | 369729 USD |
| 2017Q1 | -1.1 million USD | 365892 USD |
| 2016Q4 | -950505 USD | 495474 USD |
| 2016Q3 | -1.4 million USD | 579555 USD |
| 2016Q2 | -1.4 million USD | 567663 USD |
| 2016Q1 | -1.4 million USD | 600280 USD |
| 2015Q4 | -757233 USD | 757736 USD |
| 2015Q3 | -702748 USD | 703214 USD |
| 2015Q2 | -1.4 million USD | 907194 USD |
| 2015Q1 | -1.4 million USD | 896436 USD |
| 2014Q4 | -419479 USD | 1.1 million USD |
| 2014Q3 | -2.2 million USD | 2.7 million USD |
| 2014Q2 | -2.4 million USD | 2.9 million USD |
| 2014Q1 | -2.3 million USD | 2.8 million USD |
| 2013Q4 | -3.2 million USD | 658382 USD |
| 2013Q3 | -1.5 million USD | 993851 USD |
| 2013Q2 | -1.5 million USD | 991771 USD |
| 2013Q1 | -1.9 million USD | 1.3 million USD |
| 2012Q4 | -2.3 million USD | 1.2 million USD |
| 2012Q3 | -999034 USD | 887047 USD |
| 2012Q2 | -960265 USD | 852624 USD |
| 2012Q1 | -1.0 million USD | 893226 USD |
| 2011Q2 | 2.2 million USD | -1.3 million USD |
| 2010Q3 | 3.4 million USD | -1.3 million USD |
| 2008Q2 | -1.7 million USD | 114185 USD |
| 2008Q1 | -1.7 million USD | 108437 USD |
| 2007Q4 | -4.4 million USD | 110976 USD |
| 2007Q3 | -4.5 million USD | 112484 USD |
| 2007Q2 | -1.4 million USD | 114381 USD |
| 2007Q1 | -1.4 million USD | 109411 USD |
| 2006Q4 | -3.1 million USD | 93518 USD |
| 2006Q3 | -2.9 million USD | 88280 USD |
| 2006Q2 | -2.2 million USD | 141435 USD |
| 2006Q1 | -2.1 million USD | 136715 USD |
| 2005Q4 | -2.0 million USD | 159102 USD |
| 2005Q3 | -1.9 million USD | 165436 USD |
| 2005Q2 | -6.7 million USD | 473638 USD |
| 2005Q1 | -6.9 million USD | 492493 USD |
| 2004Q4 | -2.8 million USD | 535049 USD |
| 2004Q3 | -2.6 million USD | 497297 USD |
| 2004Q2 | -2.0 million USD | 419117 USD |
| 2004Q1 | -2.3 million USD | 462731 USD |
| 2003Q4 | -1.5 million USD | 422084 USD |
| 2003Q3 | -1.4 million USD | 545988 USD |
| 2003Q2 | -1.4 million USD | 534975 USD |
| 2003Q1 | 219881 USD | 346052 USD |
| 2002Q4 | 206172 USD | 324476 USD |
| 2002Q3 | -883112 USD | 132044 USD |
ATHE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -9.2 million USD | ? USD |
| 2022 | -8.9 million USD | 2.4 million USD |
| 2021 | -11.5 million USD | 2.4 million USD |
| 2020 | -6.9 million USD | 284049 USD |
| 2019 | -8.6 million USD | 76028 USD |
| 2018 | -6.1 million USD | 147806 USD |
| 2017 | -5.8 million USD | 101785 USD |
| 2016 | -5.8 million USD | 106592 USD |
| 2015 | -4.5 million USD | 135789 USD |
| 2014 | -12.6 million USD | 342630 USD |
| 2013 | -7.2 million USD | 140058 USD |
| 2012 | -5.3 million USD | 187326 USD |
| 2011 | -6.9 million USD | 166938 USD |
| 2010 | -4.1 million USD | 180936 USD |
| 2009 | -6.1 million USD | 345264 USD |
| 2008 | -13.0 million USD | 471462 USD |
| 2007 | -9.4 million USD | 430034 USD |
| 2006 | -8.7 million USD | 566249 USD |
| 2005 | -19.0 million USD | 2.0 million USD |
| 2004 | -6.9 million USD | 1.6 million USD |
| 2003 | -3.6 million USD | 530353 USD |
| 2002 | -3.1 million USD | 447636 USD |
| 2001 | -2.1 million USD | 261561 USD |
| 2000 | -797408 USD | 47351 USD |
| 1999 | -52041 USD | ? USD |
| 1998 | -448 USD | ? USD |
ATHE
Price: $2.10
52 week price:
Earnings Per Share: -1.88 USD
P/E Ratio: -1.05
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 8900
Market Capitalization: 23.0 million